uu.seUppsala universitets publikasjoner
Endre søk
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf
Signatures of post-zygotic structural genetic aberrations in the cells of histologically normal breast tissue that can predispose to sporadic breast cancer
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för immunologi, genetik och patologi, Medicinsk genetik och genomik. Uppsala universitet, Science for Life Laboratory, SciLifeLab.ORCID-id: 0000-0002-1701-755X
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för immunologi, genetik och patologi, Medicinsk genetik och genomik. Uppsala universitet, Science for Life Laboratory, SciLifeLab.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för immunologi, genetik och patologi, Medicinsk genetik och genomik. Uppsala universitet, Science for Life Laboratory, SciLifeLab.
Uppsala universitet, Medicinska och farmaceutiska vetenskapsområdet, Medicinska fakulteten, Institutionen för immunologi, genetik och patologi, Medicinsk genetik och genomik. Uppsala universitet, Science for Life Laboratory, SciLifeLab.
Vise andre og tillknytning
2015 (engelsk)Inngår i: Genome Research, ISSN 1088-9051, E-ISSN 1549-5469, Vol. 25, nr 10, s. 1521-1535Artikkel i tidsskrift (Fagfellevurdert) Published
Abstract [en]

Sporadic breast cancer (SBC) is a common disease without robust means of early risk prediction in the population. We studied 282 females with SBC, focusing on copy number aberrations in cancer-free breast tissue (uninvolved margin, UM) outside the primary tumor (PT). In total, 1162 UMs (1-14 per breast) were studied. Comparative analysis between UM(s), PT(s), and blood/skin from the same patient as a control is the core of the study design. We identified 108 patients with at least one aberrant UM, representing 38.3% of cases. Gains in gene copy number were the principal type of mutations in microscopically normal breast cells, suggesting that oncogenic activation of genes via increased gene copy number is a predominant mechanism for initiation of SBC pathogenesis. The gain of ERBB2, with overexpression of HER2 protein, was the most common aberration in normal cells. Five additional growth factor receptor genes (EGFR, FGFR1, IGF1R, LIFR, and NGFR) also showed recurrent gains, and these were occasionally present in combination with the gain of ERBB2. All the aberrations found in the normal breast cells were previously described in cancer literature, suggesting their causative, driving role in pathogenesis of SBC. We demonstrate that analysis of normal cells from cancer patients leads to identification of signatures that may increase risk of SBC and our results could influence the choice of surgical intervention to remove all predisposing cells. Early detection of copy number gains suggesting a predisposition toward cancer development, long before detectable tumors are formed, is a key to the anticipated shift into a preventive paradigm of personalized medicine for breast cancer.

sted, utgiver, år, opplag, sider
2015. Vol. 25, nr 10, s. 1521-1535
HSV kategori
Identifikatorer
URN: urn:nbn:se:uu:diva-265683DOI: 10.1101/gr.187823.114ISI: 000362157400016PubMedID: 26430163OAI: oai:DiVA.org:uu-265683DiVA, id: diva2:866903
Forskningsfinansiär
Swedish Cancer SocietySwedish Research CouncilSwedish Heart Lung FoundationScience for Life Laboratory - a national resource center for high-throughput molecular bioscience
Merknad

De 2 första författarna delar förstaförfattarskapet.

Tilgjengelig fra: 2015-11-04 Laget: 2015-11-02 Sist oppdatert: 2018-02-28bibliografisk kontrollert

Open Access i DiVA

fulltext(4983 kB)483 nedlastinger
Filinformasjon
Fil FULLTEXT01.pdfFilstørrelse 4983 kBChecksum SHA-512
385037df7e301f3aafe8206e3a97b09c03fe8da492f8c271e5c2b6310a0591d8c54682a194f7c580c42ec4a03afbcaa7e9d830f14cc6fa25e9b76c74412dd7be
Type fulltextMimetype application/pdf

Andre lenker

Forlagets fulltekstPubMed

Personposter BETA

Forsberg, Lars A.Rasi, ChiaraPekar, GyulaDavies, HannaLau Börjesson, JoeyHallberg, GunillaJanson, Eva TiensuuDumanski, Jan P.

Søk i DiVA

Av forfatter/redaktør
Forsberg, Lars A.Rasi, ChiaraPekar, GyulaDavies, HannaLau Börjesson, JoeyHallberg, GunillaJanson, Eva TiensuuDumanski, Jan P.
Av organisasjonen
I samme tidsskrift
Genome Research

Søk utenfor DiVA

GoogleGoogle Scholar
Totalt: 483 nedlastinger
Antall nedlastinger er summen av alle nedlastinger av alle fulltekster. Det kan for eksempel være tidligere versjoner som er ikke lenger tilgjengelige

doi
pubmed
urn-nbn

Altmetric

doi
pubmed
urn-nbn
Totalt: 995 treff
RefereraExporteraLink to record
Permanent link

Direct link
Referera
Referensformat
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Annet format
Fler format
Språk
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Annet språk
Fler språk
Utmatningsformat
  • html
  • text
  • asciidoc
  • rtf